Drug
Bexagliflozin clinical trials
Also written EGT0001442 and EGT0001474.
Keep track of what changes. Save the Bexagliflozin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2016 (5)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 16 · Other 3
Theracos (15) · Baylor Research Institute (1) · University of Virginia (1) · Yale University (1) · Newsoara Biopharma Co., Ltd. (1)
Often tested with
Tested in the same studies.
Glimepiride (2) · Sitagliptin (2) · Metformin (1) · Exenatide (1) · Finerenone (1) · Semaglutide (1) · Benazepril (1) · Captopril (1)
Studies
Open first, then newest update. How each study uses Bexagliflozin is read from its arms, and is right about nine times in ten.
Testing it · 19
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Brenzavvy
- Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)RecruitingPhase 1University of VirginiaNCT06600178Written as Brenzavvy (bexagliflozin), 20 mg Oral Tablet
- Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA StudyRecruitingPhase 4Yale UniversityNCT05612594Written as Bexagliflozin 20 mg
- Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy SubjectsStatus unknownPhase 1Newsoara Biopharma Co., Ltd.NCT05369078Written as THR-1442 20mg Single dose
- An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential HypertensionCompletedPhase 2/3TheracosNCT03514641Written as Bexagliflozin
- Bexagliflozin Drug/Drug Interaction Study With DigoxinCompletedPhase 1TheracosNCT03197324Written as Bexagliflozin
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinCompletedPhase 1TheracosNCT02956044Written as Bexagliflozin
- Bexagliflozin Efficacy and Safety TrialCompletedPhase 3TheracosNCT02558296Written as Bexagliflozin
- Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT01377844Written as EGT0001442
- Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentCompletedPhase 3TheracosNCT02836873Written as Bexagliflozin
- A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT02390050Written as Bexagliflozin tablets
- Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesCompletedPhase 3TheracosNCT02715258Written as Bexagliflozin
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedPhase 3TheracosNCT03115112Written as Bexagliflozin
- Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT01029704Written as EGT0001442
- Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy SubjectsCompletedPhase 1TheracosNCT02820298Written as Bexagliflozin
- Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic ImpairmentCompletedPhase 1TheracosNCT03557658Written as Bexagliflozin
- Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionCompletedPhase 1TheracosNCT03167411Written as Bexagliflozin
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedPhase 3TheracosNCT02769481Written as Bexagliflozin
- Absolute Bioavailability Study With BexagliflozinWithdrawnPhase 1TheracosNCT03417076Written as Bexagliflozin
Given in every arm · 1 — Bexagliflozin is usual care beside what is tested
Codes
What other systems call Bexagliflozin · ClinicalTrials.gg INT001293
- MeSH (NLM) C000705992BexagliflozinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) EY00JF42FVBEXAGLIFLOZINConfirmed FDA, NLM, Wikidata
- Wikidata Q27277423bexagliflozinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169811BexagliflozinOne source FDA
- DrugBank DB12236One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000705992 | Bexagliflozin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | EY00JF42FV | BEXAGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27277423 | bexagliflozin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169811 | Bexagliflozin | One source FDA |
| DrugBank | DB12236 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.